Cat. No. | Product name | CAS No. |
DCC5506 |
way-133537
ATP-sensitive potassium channel opener |
177476-74-3 |
DCC5507 |
Way-151693
Inhibitor of human collagenase-3 (MMP-13) |
206551-25-9 |
DCC5508 |
Way-170523
Potent and selective inhibitor of matrix metalloprotease MMP-13 (Collagenase-3) |
307002-73-9 |
DCC5509 |
Way-171230
Inhibitor of matrix metalloproteinase-1 (MMP-1) |
|
DCC5510 |
Way-260022
Potent and Selective Inhibitor of the Norepinephrine Transporter |
850692-43-2 |
DCC5511 |
Way-316606 Hydrochloride
Secreted frizzled-related protein-1 (sFRP-1) modulaitor |
1781835-02-6 |
DCC5512 |
Wb-308
Novel inhibitor of The epidermal growth factor receptor (EGFR), decreasing NSCLC cell proliferation and colony formation, by causing G2/M arrest and apoptosis. |
1373764-87-4 |
DCC5513 |
Wb4-24
Non-peptide GLP-1 receptor agonist, blocking inflammatory nociception by stimulating β-endorphin release from spinal microglia |
|
DCC5514 |
Wck5153
Novel Inhibitor of PBP2, Showing Potent β-Lactam Enhancer Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones |
1436862-38-2 |
DCC5515 |
We-14 Tfa Salt
Highly conserved neuropeptide derived from Chromogranin A (Parathyroid Secretory Protein 1) |
115136-18-0 |
DCC5516 |
Web2347
Novel very potent and long acting hetrazepinoic PAF-antagonist |
114800-19-0 |
DCC5517 |
Wen05-03
Novel inhibitor of type III secretion system ATPase EscN from enteropathogenic Eecherichia coli |
|
DCC5518 |
Wfq-228
Novel fluoroquinolone antibiotic with potent antimicrobial activity, showing the potential to overcome major drug resistance; its antimicrobial activity was less affected by both pump-mediated efflux and QRDR mutations in P. aeruginosa compared with LVX a |
|
DCC5519 |
Whz-04
Novel Anti-malarial Plasmodium-Selective Proteasome Inhibitor |
|
DCC5520 |
Win-35428
Dopamine reuptake inhibitor, also having some SERT affinity |
50370-56-4 |
DCC5521 |
Win-64338
B2 bradykinin receptor antagonist |
151039-63-3 |
DCC5522 |
Withangulatin A
Natural potent antitumoragent, targeting sarco/endoplasmic reticulum calcium-ATPase (SERCA)2 |
120824-03-5 |
DCC5523 |
Wj35435
Novel dual inhibitor of histone deacetylase and topoisomerase I |
1620054-84-3 |
DCC5524 |
Wjd008
Novel potent dual inhibitor of phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR), preventing PI3K signaling and inhibiting the proliferation of transformed cells with oncogenic PI3K mutant |
1309087-83-9 |
DCC5525 |
Wms-1410
Novel GluN2B-specific NMDAR antagonist, completely preventing the decrease in insulin secretion of about 32 % provoked by a 24-h-treatment with NMDA/glycine, eliminating NMDA-induced changes in the oxidation status of the islet cells and elevating the sen |
|
DCC5526 |
Wms-2539
Potent uncompetitive NMDA receptor antagonist |
|
DCC5527 |
Wn1316
Unique neuroprotectant against oxidative injury, being a highly promising remedy for the treatment of amyotrophic lateral sclerosis (ALS) |
1356959-71-1 |